Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | AIP | O00170 | 1/20 | 0.60 |
| ▸ | SGTA | O43765 | 1/20 | 0.60 |
| ▸ | TOMM70 | O94826 | 1/20 | 0.60 |
| ▸ | STIP1 | P31948 | 1/20 | 0.60 |
| ▸ | PPP5C | P53041 | 1/20 | 0.60 |
| ▸ | FKBP4 | Q02790 | 1/20 | 0.60 |
| ▸ | PPID | Q08752 | 1/20 | 0.60 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.60 |
| ▸ | FKBP8 | Q14318 | 1/20 | 0.60 |
| ▸ | TOMM34 | Q15785 | 1/20 | 0.60 |
| ▸ | DNAJC7 | Q99615 | 1/20 | 0.60 |
| ▸ | AIPL1 | Q9NZN9 | 1/20 | 0.60 |
| ▸ | STUB1 | Q9UNE7 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 6/20 | 0.55 |
| ▸ | HPGD | P15428 | 5/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13711828 | 0.76 | ALDH1A1 (0.50) | CYP1A2AIPSGTATOMM70STIP1 | |
| SCHEMBL8288688 | 0.73 | ALDH1A1 (0.91) | CYP1A2AIPSGTATOMM70STIP1 | |
| SCHEMBL3125764 | 0.72 | ALDH1A1 (0.88) | CYP1A2AIPSGTATOMM70STIP1 | |
| SCHEMBL8288672 | 0.72 | ALDH1A1 (0.93) | CYP1A2AIPSGTATOMM70STIP1 | |
| SCHEMBL8288697 | 0.71 | ALDH1A1 (0.86) | CYP1A2AIPSGTATOMM70STIP1 | |
| SCHEMBL17817425 | 0.69 | ALDH1A1 (0.97) | AIPSGTATOMM70STIP1PPP5C | |
| SCHEMBL10665672 | 0.66 | HSP90AA1 (0.61) | ALDH1A1LMNAKMT2AMEN1POLB | |
| SCHEMBL10667145 | 0.66 | HSP90AA1 (0.61) | ALDH1A1LMNAKMT2AMEN1POLB | |
| SCHEMBL3869753 | 0.65 | MAPT (0.52) | AIPSGTATOMM70STIP1PPP5C | |
| SCHEMBL28737637 | 0.64 | SCD (0.41) | CYP1A2MAPTLMNAKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3229811-B1 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | GRI BIO INC (US) | 2021-02-24 | — | — | EP | disclosed |
| WO-2016094226-A1 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | GLYCOREGIMMUNE, INC. (US) | 2016-06-16 | — | — | WO | disclosed |
| US-20160158258-A1 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | ALTIUM GROWTH FUND, LP | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160158258-A1 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | RXRA, RXRG, CX3CR1 | CYP1A2 2743/4885AIP 1880/4885SGTA 3770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.